{
  "docId": "019dd923-622c-750b-8b9a-2a2468219173",
  "docSlug": "ce565b841c40",
  "documentTitle": "Nevro Corp. (NVRO)",
  "authorId": "58_Scorpion_Capital",
  "authorName": "Kir Kahlon",
  "documentKindSlug": "activist-deck",
  "documentKindLabel": "Activist deck",
  "sourceTypeSlug": "short_seller",
  "sourceTypeLabel": "Short seller",
  "presentationDate": "2021-01-07 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.3333334,
  "pageNumber": 112,
  "pageCount": 239,
  "prevPage": 111,
  "nextPage": 113,
  "slideType": "expose_contradiction",
  "function": "expose_contradiction",
  "density": "overcrowded",
  "nDataPoints": 0,
  "notes": "The slide uses highlighted text to emphasize key claims about doctor behavior and financial incentives.",
  "elementsJson": [
    "headline_text",
    "paragraph",
    "quote_block",
    "footnote"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-622c-750b-8b9a-2a2468219173/112",
  "deckHref": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
  "deckJsonHref": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json",
  "deckAnchorHref": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-112",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "Several KOL’s indicated that doctors who deny the existence of explants do too few implants per year to notice or care that they’re failing.",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd953-3f3d-76db-b33f-eb5d12415f59",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.88,
        "x": 0.06,
        "y": 0.14
      },
      "kind": "paragraph",
      "text": "Several KOL's indicated that doctors who deny the existence of explants do too few implants per year to notice or care that they're failing.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9ff9fd77-829e-4770-9e08-ec81b9c76161",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.88,
        "x": 0.06,
        "y": 0.23
      },
      "kind": "quote",
      "text": "Then you have Kaiser docs like one who said to me that he thinks patients like Nevro. I said, \"You think patients like it because you do 10 implants a year and you really don't know.\" So there are a lot of Nevro doctors that don't do many implants, and then you have higher volumes ones at these surgery centers where it's a financial decision because of the price.",
      "attrs": null,
      "subkind": "testimonial",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "52dcf537-bff9-40b3-8907-2ed1e0d021d7",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.22,
        "w": 0.88,
        "x": 0.06,
        "y": 0.38
      },
      "kind": "quote",
      "text": "For the low volume implanters, Nevro said, hey you don't have to test, you don't have to elicit paresthesias, you just put it in this one place T9/10 and that's all you have to do. The ease of implanting took the whole thought process out. When we used to teach neuromodulation 10-15 years ago, there were all kinds of algorithms. So that was incredibly attractive to implanters who didn't really do many - this is easy. You just put it in. And initially those few implants did really well. You thought things are good. After a while it didn't do so good, but you weren't doing enough neuromodulation to really pay attention to it.",
      "attrs": null,
      "subkind": "testimonial",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "58c9ab0f-cf5c-4d56-b4f3-cb360779c589",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "quote",
      "text": "“Then you have Kaiser docs like one who said to me that he thinks patients like Nevro. I said, \"You think patients like it because you do 10 implants a year and you really don't know.\" So there are a lot of Nevro doctors that don't do many implants, and then you have higher volumes ones at these surgery centers where it's a financial decision because of the price.” —KOL, former high volume Nevro implanter; “For the low volume implanters, Nevro said, hey you don't have to test, you don't have to elicit paresthesias, you just put it in this one place T9/10 and that’s all you have to do. The ease of implanting took the whole thought process out. When we used to teach neuromodulation 10-15 years ago, there were all kinds of algorithms. So that was incredibly attractive to implanters who didn't really do many - this is easy. You just put it in. And initially those few implants did really well. You thought things are good. After a while it didn't do so good, but you weren't doing enough neuromodulation to really pay attention to it.” —KOL, former high volume Nevro implanter",
      "attrs": null,
      "subkind": null,
      "toolName": "Authority citation",
      "toolSlug": "authority-citation",
      "confidence": null,
      "componentId": "019dd953-3f3d-76db-b33f-eca232a8b76b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.2,
        "x": 0.06,
        "y": 0.95
      },
      "kind": "source-note",
      "text": "Source: Consultation calls with experts",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ff7a8daf-f998-4a07-a09b-33236c72e4d3",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.88,
        "x": 0.06,
        "y": 0.1
      },
      "kind": "title",
      "text": "8. Nevro's response to its explants crisis appears to be marked by denial, cover-up, retaliation, and patient/doc manipulation",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f8058294-3fb8-46c0-9f90-695942e85c82",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.35,
        "x": 0.06,
        "y": 0.04
      },
      "kind": "title",
      "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1b7ca41e-b720-45c0-8ac7-8d1c16882fa1",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 150,
      "from": 51,
      "beatId": "903c076a-f368-4ca1-844c-277874c1afb2",
      "arcName": "Overcoming the Monster",
      "arcSlug": "overcoming-monster",
      "beatName": "The Victory",
      "beatSlug": "overcoming-monster-the-victory",
      "evidence": "The deck presents a conclusion that Nevro's problems are insurmountable",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Turn",
      "parentBeatSlug": "turn"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}